BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs6983267, BRAF, Response to oxidative stress, Obesity, Liver, Amniocentesis, Cisplatin)
Bookmark Forward

QuickView for indoleamine 2,3-dioxygenase activity (biogroup)


Body Atlas

Most Correlated Tissues

  1. Placenta
  2. Eosinophil of peripheral blood
  3. Liver
  4. Lung
  5. Endometrium
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Salmonella infection
  2. Eczema
  3. Herpes simplex type 2 infection
  4. Alpha-1-antitrypsin deficiency
  5. Legionella infection
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. interferon gamma receptor
  2. temsirolimus
  3. ActHIB
  4. Menomune
  5. enterotoxin I, staphylococcal
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. RMST
  2. NDUFB8
  3. LRP5
  4. HOXA10
  5. HOXD11
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. Placental expression profiling in the first and third trimesters of normal pregnancy
  2. Hepatocellular carcinoma expression compared to normal and cirrhotic liver tissue
  3. Identification of Biomarkers of response to IFNg during endotoxin tolerance
  4. Lung biopsies from asthmatics pre- and post- Flovent treatment
  5. Dendritic cell subsets in human tonsils and blood
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activit…
  2. Indoleamine 2, 3-dioxygenase activity during chemotherapy or trastuzumab therapy in patients with br…
  3. Indoleamine 2,3-dioxygenase activity and expression in patients with chronic lymphocytic leukemia.
  4. Serum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosis.
  5. Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplan…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)
  2. Study of Indoleamine 2,3-dioxygenase Activity, Serum Levels of Cytokines, BDNF, BH4 and Mirtazapine …
  3. NLG802 Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors
  4. Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors
  5. Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.